Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gammopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT02920190
What this trial is testing

Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat

Who this might be right for
Monoclonal GammopathiesOverweightObesity
University of Miami
Not applicableStudy completedNCT03832140
What this trial is testing

Frequency and Characteristics of Pruritus in Patients With Monoclonal Gammopathy

Who this might be right for
PruritusMonoclonal Gammopathy
University Hospital, Brest 281
Early research (Phase 1)Ended earlyNCT00004058
What this trial is testing

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Medicine and Dentistry of New Jersey
Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Testing effectiveness (Phase 2)Study completedNCT01063907
What this trial is testing

KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Kyowa Kirin Co., Ltd. 95
Testing effectiveness (Phase 2)WithdrawnNCT01571726
What this trial is testing

Imaging Studies and the Development of Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT07598422
What this trial is testing

Assess the Effectiveness and Safety of Canakinumab in Clinical Use in Patients With Schnitzler's Syndrome

Who this might be right for
Schnitzler Syndrome
Novartis Pharmaceuticals 10
Not applicableLooking for participantsNCT02269592
What this trial is testing

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Myelodysplastic SyndromesHematological Malignancies+5 more
Dana-Farber Cancer Institute 10,000
Not applicableStudy completedNCT02033928
What this trial is testing

Comprehensive Frailty Assessment

Who this might be right for
Myeloma, MultipleParaproteinemiasHematologic Neoplasms
Ohio State University Comprehensive Cancer Center 111
Large-scale testing (Phase 3)Study completedNCT00006348
What this trial is testing

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Alliance for Clinical Trials in Oncology 100
Not applicableLooking for participantsNCT06644625
What this trial is testing

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

Who this might be right for
Multiple MyelomaMultiple Myeloma ProgressionMonoclonal Gammopathy of Undetermined Significance (MGUS)+2 more
Wake Forest University Health Sciences 1,665
Large-scale testing (Phase 3)Study completedNCT00719563
What this trial is testing

American Ginseng in Treating Patients With Fatigue Caused by Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFatigueLeukemia+7 more
Alliance for Clinical Trials in Oncology 364
Testing effectiveness (Phase 2)Study completedNCT01276522
What this trial is testing

Efficacy and Safety of Canakinumab in Schnitzler Syndrome

Who this might be right for
Schnitzler Syndrome
Radboud University Medical Center 8
Not applicableNot Yet RecruitingNCT06750965
What this trial is testing

Multi-center Screening for Serum M Protein

Who this might be right for
Monoclonal GammopathyMultiple MyelomaM-protein
Zhujiang Hospital 10,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05581875
What this trial is testing

Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseNeoplasms+6 more
Hellenic Society of Hematology 48
Testing effectiveness (Phase 2)UnknownNCT00006466
What this trial is testing

Beta Alethine in Treating Patients With Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell NeoplasmPrecancerous Condition
LifeTime Pharmaceuticals
Not applicableStudy completedNCT01543100
What this trial is testing

Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy

Who this might be right for
Monoclonal GammopathyMonoclonal Gammopathy of Undetermined SignificationMyeloma
Rennes University Hospital 60
Not applicableLooking for participantsNCT05965115
What this trial is testing

The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Shanghai Zhongshan Hospital 10,000
Not applicableEnrolling By InvitationNCT06472830
What this trial is testing

MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening Study

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance
Mayo Clinic 1,000
Not applicableLooking for participantsNCT06559033
What this trial is testing

Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceMyeloma Multiple
University Hospital, Rouen 300
Next Page